trending Market Intelligence /marketintelligence/en/news-insights/trending/b1oNYwpLeCB0kL7wEp2ibA2 content esgSubNav
In This List

Heron Therapeutics commences $150M common stock offering

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes

Blog

Investment Banking Essentials Newsletter April Edition - 2022


Heron Therapeutics commences $150M common stock offering

Heron Therapeutics Inc. said it commenced an underwritten public offering of $150 million of shares of its common stock.

Heron will grant underwriters a 30-day option to purchase up to an additional 15% of the shares in the offering.

BofA Merrill Lynch, Cowen and Co. LLC and Leerink Partners LLC are acting as joint book-running managers for the offering.